Skip to content

Statement 5.4

“Hospital pharmacists should ensure the reporting of adverse drug reactions and medication errors to regional or national pharmacovigilance programmes or patient safety programmes.”

What does it mean for patients? Adverse drug reactions can occur and must be monitored constantly after marketing approval. The aim of pharmacovigilance reporting programs is to enable authorities to collect the necessary data update the risk-benefit assessments regarding medicines.

What does it mean for healthcare professionals? Reporting of adverse drug reactions is a requirement in order to obtain sufficient data to improve quality and safety of medication practices. Hospital pharmacists can support healthcare professionals to increase reporting and review medication practices.

What does it mean for Hospital Pharmacists? pharmacists should assist health care professionals to increase reporting. Hospital pharmacists should be involved reviewing and monitoring data and define any action needed to improve internal medication practices.

The Fatebenefratelli e Oftalmico Hospital is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.